Oppenheimer & Co. Inc. Has $364,000 Stake in Oscar Health, Inc. (NYSE:OSCR)

Oppenheimer & Co. Inc. decreased its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 61.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,112 shares of the company's stock after selling 43,694 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Oscar Health were worth $364,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. KBC Group NV lifted its position in shares of Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after buying an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC bought a new stake in Oscar Health in the 4th quarter valued at $100,000. Alberta Investment Management Corp bought a new position in shares of Oscar Health during the 4th quarter valued at about $138,000. SMART Wealth LLC purchased a new position in shares of Oscar Health during the fourth quarter valued at about $180,000. Finally, Tempus Wealth Planning LLC purchased a new stake in shares of Oscar Health in the fourth quarter worth about $181,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Stock Performance

NYSE:OSCR traded down $0.85 during midday trading on Tuesday, hitting $14.69. The company's stock had a trading volume of 8,944,201 shares, compared to its average volume of 3,583,325. Oscar Health, Inc. has a fifty-two week low of $12.43 and a fifty-two week high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market cap of $3.68 billion, a P/E ratio of -733.88 and a beta of 1.75. The firm's 50 day moving average is $15.21 and its 200-day moving average is $16.49.

Remove Ads

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Jefferies Financial Group initiated coverage on Oscar Health in a research note on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $21.56.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.